Saccharomyces Boulardii
Complete medical breakdown of Saccharomyces Boulardii. Understand the pharmacokinetics, clinical indications, and how to safely integrate it into your protocol.
Clinical Summary
Non-pathogenic yeast; first-line indication for prevention of post-antibiotic diarrhea.
Pharmacokinetics & Bioavailability
When evaluating Saccharomyces Boulardii, the most critical factor is its absorption rate. Currently, the clinical bioavailability score for this specific chemical form is rated at N/A.
This high absorption rate ensures that the active compound reaches systemic circulation without causing excessive gastrointestinal distress, provided it is taken correctly.
Optimal Protocol Instructions
- Best Time: During a meal
- Elemental Dose: 5 Milliards CFU
Contraindications & Warnings
Do not take Saccharomyces Boulardii without consulting your physician if you fall into any of the following categories.
Patients with central venous catheter (fungemia risk)
Medical Board Pick
We have analyzed the raw material sourcing for Saccharomyces Boulardii to ensure it meets strict clinical standards.
Supports our independent research